Professor, Harvard Medical School; Vice Chair, Faculty Affairs, Department of Emergency MedicineMassachusetts General Hospital, Boston, MA, USABoston, Massachusetts, United States
PB1061 - A phase 3 trial of TAK-330 (4-factor prothrombin complex concentrate [4F-PCC]) vs standard-of-care 4F-PCCs for FXa inhibitor-induced anticoagulation reversal before urgent surgery/invasive procedure
Tuesday, June 25, 202413:45 – 14:45 ICT
